Protective particles allow engineered probiotics to report gut disease: Platform could enable minimally invasive disease monitoring, smart therapeutics -- ScienceDaily

  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 85 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 37%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Bioengineers developed a platform that enhances survival and function of probiotics engineered to diagnose inflammatory bowel disease in animals. The technology holds promise for minimally invasive disease monitoring and advanced smart therapeutics.

Trust your gut? Your doctor likely will, too. Probiotics engineered to sense and report signs of bowel inflammation could deliver firsthand knowledge of your system's inner workings -- provided they are not killed or dispersed in the process.

"For our proof-of-concept study, we chose inflammatory bowel disease, an autoimmune disorder that causes painful and recurrent inflammation flares," said Elena Musteata, a graduate student in systems, synthetic and physical biology in the Tabor lab."But gut health plays many important roles in the human body, affecting metabolism, immunity, brain function and other systems.

According to Musteata, a quicker diagnosis could lead to better patient outcomes:"Especially with IBD, it's very important to minimize the delay between symptom onset and treatment," she said."Having a way to assess gut health within a short amount of time and then take action could really generate a significant advance in the clinical management of chronic inflammation and other gut-related disorders.

"Our study demonstrated that encapsulating biosensor bacteria in protective alginate particles enables their robust survival and diagnostic function in live animals," Musteata said."We characterized the effect of encapsulation on the viability, population dynamics and performance of a thiosulfate-sensing bacterial strain previously developed in our lab."

While developing and optimizing the platform was a challenging process, the researchers stressed the necessity of ensuring its reproducibility as a prerequisite for eventual clinical use."As we worked on developing our platform, we encapsulated bacteria countless times, optimizing each step of the process along the way. There were so many aspects that needed to be characterized well in order to make a clinically translatable product," Aghlara-Fotovat said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 452. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Infectious Diseases News -- ScienceDailyRead the latest medical research on the prevention, management, and treatment of infectious diseases. Read articles on HINI, influenza, C. difficile, HIV and AIDS, hepatitis, herpes, STDs and more.
Source: ScienceDaily - 🏆 452. / 53 Read more »